KRONOX LAB SCIENCES LIMITED (NSE: KRONOX, BSE: 544187) is a Vadodara, Gujarat-based company in the Industrial Process Chemicals industry. With a market capitalisation of ₹706 Cr, it ranks #1,802 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 6 in Industrial Process Chemicals. At ₹191.30 (as of 16 Nov 2026), the share price is 16.0% below its 52-week high of ₹227.74 and 99.3% above its 52-week low of ₹96.00. The share price is up 32.4% over one year and up 24.2% over three months.
| Current Price | ₹191.30 |
|---|---|
| Market Cap | ₹706 Cr |
| NSE Symbol | KRONOX |
| BSE Code | 544187 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Industrial Process Chemicals |
| P/E Ratio | 26.2 |
| Return on Equity | 26.82% |
| Return on Assets | 18.08% |
| 52-Week Range | ₹96.00 – ₹227.74 |
| 1-Year Price Change | +32.4% |
| 3-Month Price Change | +24.2% |
| Beta (1Y) | 0.59 |
| Dividend Yield | 0.26% |
| Headquarters | Vadodara, Gujarat |
| Website | www.kronoxlabsciences.com |
| Revenue | ₹27 Cr |
|---|---|
| Net Profit | ₹6 Cr |
| Net Margin | 24.0% |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
KRONOX LAB SCIENCES LIMITED reported revenue of ₹27 Cr in Q2 FY27, up 5.1% from ₹26 Cr in Q2 FY26 and down 5.5% from ₹28 Cr in Q1 FY27. It posted a net profit of ₹6 Cr for the quarter, against a net profit of ₹7 Cr in Q2 FY26 (down 3.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹24 Cr (Q1 FY26) to ₹28 Cr (Q1 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹27 Cr | ₹6 Cr | 24.0% |
| Q1 FY27 | ₹28 Cr | ₹7 Cr | 25.7% |
| Q4 FY26 | ₹26 Cr | ₹8 Cr | 30.6% |
| Q3 FY26 | ₹25 Cr | ₹7 Cr | 26.1% |
| Q2 FY26 | ₹26 Cr | ₹7 Cr | 26.2% |
| Q1 FY26 | ₹24 Cr | ₹6 Cr | 25.9% |
| Q4 FY25 | ₹26 Cr | ₹6 Cr | 24.2% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 64.26% of KRONOX LAB SCIENCES LIMITED's shares as of Sept 2026, against 74.21% in Sept 2025 (−9.95 percentage points).
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
1. Manufacturing of High Purity Specialty Fine Chemical-This segment manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacturing of High Purity Specialty Fine Chemical-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| KRONOX LAB SCIENCES LIMITED | ₹706 Cr | 26.2 | 26.82% | ₹27 Cr | +32.4% |
| Dharamsi Morarji Chemical Co | ₹626 Cr | 23 | 11.49% | ₹273 Cr | -16.0% |
| CHEMBOND CHEMICALS LIMITED | ₹619 Cr | 17.3 | 16.77% | ₹96 Cr | +45.5% |
| Devson Catalyst | ₹484 Cr | 29.1 | — | — | — |
| Polson Ltd. | ₹126 Cr | 26.6 | 3.68% | — | -13.5% |
| Paragon Fine and Speciality Chemical Limited | ₹95 Cr | — | 9.64% | — | -15.7% |
Listed by market capitalisation. Ratios are shown for context only.
KRONOX LAB SCIENCES LIMITED is trading at ₹191.30, with a market capitalisation of ₹706 Cr.
KRONOX LAB SCIENCES LIMITED operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Industrial Process Chemicals).
KRONOX LAB SCIENCES LIMITED has a P/E of 26.2 and a return on equity of 26.82%.
KRONOX LAB SCIENCES LIMITED is listed on the NSE under the symbol KRONOX and on the BSE under the scrip code 544187.
KRONOX LAB SCIENCES LIMITED's share price is up 32.4% over one year and up 24.2% over three months. Its 52-week range is ₹96.00 to ₹227.74.
In Q2 FY27, KRONOX LAB SCIENCES LIMITED reported revenue of ₹27 Cr and net profit of ₹6 Cr (standalone, parsed from the company's exchange filing).
KRONOX LAB SCIENCES LIMITED reported revenue of ₹27 Cr in Q2 FY27, up 5.1% from ₹26 Cr in Q2 FY26 and down 5.5% from ₹28 Cr in Q1 FY27.
Promoters held 64.26% of KRONOX LAB SCIENCES LIMITED's shares as of Sept 2026, against 74.21% in Sept 2025 (−9.95 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.